{"DataElement":{"publicId":"7652409","version":"1","preferredName":"Tumor Mass  Head and Neck Squamous Cell Carcinoma Histologic Type","preferredDefinition":"The type of tissue in which a carcinoma originated in any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.","longName":"6796606v1.0:7652408v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"6796606","version":"1","preferredName":"Tumor Mass Histologic Type","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells._Refers to the type of tissue in which a tumor originated.","longName":"4976411v1.0:2673286v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"4976411","version":"1","preferredName":"Tumor Mass","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","longName":"C98275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Mass","conceptCode":"C98275","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1DC5FA96-6845-8A34-E050-BB89AD4344BC","latestVersionIndicator":"Yes","beginDate":"2015-08-20","endDate":null,"createdBy":"DAVISJ","dateCreated":"2015-08-20","modifiedBy":"ONEDATA","dateModified":"2015-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2673286","version":"1","preferredName":"Histologic Type","preferredDefinition":"Refers to the type of tissue in which a tumor originated.","longName":"C61478","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3820C878-7530-31CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-20","endDate":null,"createdBy":"UMLLOADER_BCR","dateCreated":"2007-08-20","modifiedBy":"ONEDATA","dateModified":"2007-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8C3F2573-4FAB-6BB5-E053-F662850AE327","latestVersionIndicator":"Yes","beginDate":"2019-06-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-06-26","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Upd RD to \"Qualified\"; CPTAC released AI. 1/2/20 jk Released per CPTAC SME (Linda) for PRAD Baseline CRF. 7/26/19 jk Updated OC term to Tumor Mass; used on multiple CPTAC CRFs.  6/26/19 jk created for CPTAC Baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7652408","version":"1","preferredName":"Head and Neck Squamous Cell Carcinoma Histologic Type","preferredDefinition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands._Refers to the type of tissue in which a tumor originated._Something distinguishable as an identifiable class based on common qualities.","longName":"7652408v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AAB075-EC3A-0379-E053-4EBD850ABF80","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"Verrucous Carcinoma","valueDescription":"Verrucous Carcinoma","ValueMeaning":{"publicId":"4928866","version":"1","preferredName":"Verrucous Carcinoma","longName":"4928866","preferredDefinition":"A well differentiated squamous cell carcinoma characterized by a papillary growth pattern, acanthosis, mild cytologic atypia, and pushing tumor margins. The most commonly affected anatomic sites are the oral cavity, nasal cavity, larynx, esophagus, anus, vagina, vulva, and the plantar region of the foot.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Verrucous Carcinoma","conceptCode":"C3781","definition":"A well differentiated squamous cell carcinoma characterized by a papillary growth pattern, acanthosis, mild cytologic atypia, and pushing tumor margins. The most commonly affected anatomic sites are the oral cavity, nasal cavity, larynx, esophagus, anus, vagina, vulva, and the plantar region of the foot.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1C8123EC-E5FF-9C16-E050-BB89AD436144","latestVersionIndicator":"Yes","beginDate":"2015-08-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-08-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AAB075-EC4E-0379-E053-4EBD850ABF80","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"Spindle Cell Squamous Cell Carcinoma","valueDescription":"Spindle Cell (Sarcomatoid) Squamous Cell Skin Carcinoma","ValueMeaning":{"publicId":"6774948","version":"1","preferredName":"Spindle Cell (Sarcomatoid) Squamous Cell Skin Carcinoma","longName":"6774948","preferredDefinition":"A squamous cell carcinoma of the skin with a prominent spindle cell component.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Spindle Cell Squamous Carcinoma","conceptCode":"C4666","definition":"A squamous cell carcinoma of the skin with a prominent spindle cell component.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A956DE3-10AC-246C-E053-F662850ABDDA","latestVersionIndicator":"Yes","beginDate":"2019-06-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-05","modifiedBy":"ONEDATA","dateModified":"2019-06-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AAB075-EC63-0379-E053-4EBD850ABF80","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"Papillary Squamous Cell Carcinoma","valueDescription":"Papillary Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3081854","version":"1","preferredName":"Papillary Squamous Cell Carcinoma","longName":"3081854","preferredDefinition":"A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Squamous Cell Carcinoma","conceptCode":"C4102","definition":"A well differentiated squamous cell carcinoma characterized by a papillary, exophytic growth pattern and hyperkeratosis. The most commonly affected anatomic sites are the larynx, penis, cervix, vagina, and vulva.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-46D1-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"COOPERM","dateModified":"2011-08-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AAB075-EC6E-0379-E053-4EBD850ABF80","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"Basaloid Squamous Cell Carcinoma","valueDescription":"Basaloid Squamous Cell Carcinoma","ValueMeaning":{"publicId":"3081851","version":"1","preferredName":"Basaloid Squamous Cell Carcinoma","longName":"3081851","preferredDefinition":"A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Basaloid Squamous Cell Carcinoma","conceptCode":"C54244","definition":"A squamous cell carcinoma characterized by the presence of cells with hyperchromatic nuclei, scant amount of cytoplasm, and peripheral nuclear palisading.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDDDAE-4668-1D2D-E040-BB89AD436AC9","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"SOKKERL","dateModified":"2017-12-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AAB075-EC83-0379-E053-4EBD850ABF80","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"Adenosquamous Carcinoma","valueDescription":"Adenosquamous Carcinoma","ValueMeaning":{"publicId":"4264016","version":"1","preferredName":"Adenosquamous Carcinoma","longName":"4264016","preferredDefinition":"A carcinoma composed of malignant glandular cells and malignant squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-11A0-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AAB075-EC8E-0379-E053-4EBD850ABF80","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"Acantholytic Squamous Cell Carcinoma","valueDescription":"Acantholytic Squamous Cell Skin Carcinoma","ValueMeaning":{"publicId":"4263939","version":"1","preferredName":"Acantholytic Squamous Cell Skin Carcinoma","longName":"4263939v1.00","preferredDefinition":"A histologic variant of squamous cell carcinoma that arises from the skin. It is characterized by loosening of the intercellular bridges between the malignant cells which results in acantholysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Acantholytic Squamous Cell Carcinoma","conceptCode":"C4460","definition":"A histologic variant of squamous cell carcinoma that arises from the skin. It is characterized by loosening of the intercellular bridges between the malignant cells which results in acantholysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63D55FF-34E4-F699-E040-BB89AD433A6C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"CLOHNES","dateModified":"2023-06-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AAB075-ECA3-0379-E053-4EBD850ABF80","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"},{"value":"Squamous Cell Carcinoma, conventional","valueDescription":"Squamous Cell Carcinoma","ValueMeaning":{"publicId":"4264988","version":"1","preferredName":"Squamous Cell Carcinoma","longName":"4264988","preferredDefinition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F681E9E5-3EBF-E912-E040-BB89AD433874","latestVersionIndicator":"Yes","beginDate":"2014-04-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C1AAB075-ECB8-0379-E053-4EBD850ABF80","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7652407","version":"1","preferredName":"Head and Neck Squamous Cell Carcinoma Histologic Type Type","preferredDefinition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.:Refers to the type of tissue in which a tumor originated.:Something distinguishable as an identifiable class based on common qualities.","longName":"C34447:C61478:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Head and Neck Squamous Cell Carcinoma","conceptCode":"C34447","definition":"A squamous cell carcinoma that arises from any of the following anatomic sites: lip and oral cavity, nasal cavity, paranasal sinuses, pharynx, larynx, and salivary glands.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Type","conceptCode":"C61478","definition":"Refers to the type of tissue in which a tumor originated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1AAB075-EC12-0379-E053-4EBD850ABF80","latestVersionIndicator":"Yes","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"ONEDATA","dateModified":"2021-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1AAB075-EC23-0379-E053-4EBD850ABF80","latestVersionIndicator":"Yes","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"COLBERTM","dateModified":"2022-09-20","changeDescription":null,"administrativeNotes":"9/20/22 Released as part of HNSCC Path Review per jk. mr;","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"7634287","version":"1","longName":"HNSCC Pathology Review","context":"OCCPR"},{"publicId":"7218867","version":"1","longName":"Head and Neck","context":"OCCPR"},{"publicId":"7634285","version":"1","longName":"HNSCC Baseline","context":"OCCPR"},{"publicId":"7638999","version":"1","longName":"HNSCC Local Pathology","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"C1A9F842-072B-1AAD-E053-4EBD850AC3B4","latestVersionIndicator":"Yes","beginDate":"2021-05-06","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-05-06","modifiedBy":"COLBERTM","dateModified":"2022-09-20","changeDescription":"7/12/21 jk added HNSCC Path Rpt CSI. 6/30/21 jk updated def to match other tumor types.  5/6/21 ls created for HNSCC Baseline CRF.","administrativeNotes":"9/8/22 Added HNSCC Local Path CS/CSI. mr; 9/20/22 Released per jk. mr;","unresolvedIssues":null,"deletedIndicator":"No"}}